 | |
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1997 |
| Headquarters | Chippenham, England, UK |
Number of locations | 5 (2019) |
Key people | Bruno Angelici, Chairman Michael Austwick, (CEO) |
| Revenue |  £190.6 million (2020)[1] |
| £132.8 million (2020)[1] | |
| £122.4 million (2020)[1] | |
Number of employees | 450 (2021)[2] |
| Parent | Philip Morris International |
| Website | www |
Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England which develops inhaled medicines and makes inhaler devices. The company was listed on the London Stock Exchange until it was acquired by Philip Morris International in September 2021.
- ^ a b c "Annual Results 2020" (PDF). Vectura Group. Retrieved 18 March 2021.
- ^ "Executing on our inhaled specialist CDMO strategy" (PDF). Vectura Group. 14 January 2021. Retrieved 3 March 2021.